Skip to main content
Journal ArticleOPEN ACCESS

Phase 2a safety and immunogenicity testing of DNA and recombinant modified vaccinia ankara virus vaccines expressing virus-like particles

  • Goepfert P
  • Elizaga M
  • Montefiori D
  • et al.
Retrovirology (2012) 9(S2)
DOI: 10.1186/1742-4690-9-s2-o56
N/ACitations
Citations of this article
3Readers
Mendeley users who have this article in their library.

This article is free to access.

Cite

CITATION STYLE

APA

Goepfert, P., Elizaga, M., Montefiori, D., Hural, J., DeRosa, S., Tomaras, G., … Robinson, H. (2012). Phase 2a safety and immunogenicity testing of DNA and recombinant modified vaccinia ankara virus vaccines expressing virus-like particles. Retrovirology, 9(S2). https://doi.org/10.1186/1742-4690-9-s2-o56

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free